About Us: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
No edit summary
No edit summary
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:
'''Goals'''
'''Goals'''


* Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
*Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
* Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
*Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
* Engage community experts and their trainees in curating, updating and utilizing content.
*Engage community experts and their trainees in curating, updating and utilizing content.
* Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
*Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
* Facilitate building educational content that describes the latest advancements in the field.
*Facilitate building educational content that describes the latest advancements in the field.




Line 16: Line 16:


The global hub for clinical cancer genomic aberrations.
The global hub for clinical cancer genomic aberrations.
'''Support'''
The CCGA is a [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>]-supported resource.




'''Leadership'''
'''Leadership'''


Meet our '''<u>[[Leadership|Editorial Leadership]]</u>''', '''<u>[[CCGA Workgroup|CCGA Workgroup Members]]</u>''' and [[Communications Liaison|<u>'''Communications Liaison'''</u>]].
Meet our <u>[[Leadership|Editorial Leadership]]</u>, <u>[[CCGA Workgroup|CCGA Workgroup Members]]</u> and [[Communications Liaison|<u>Communications Liaison</u>]].
<br />
<br />

Revision as of 16:20, 11 May 2021

Mission

The CCGA is a global collaborative effort to describe clinical context-based knowledge for gene- and chromosome-level abnormalities observed in cancer.


Goals

  • Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
  • Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
  • Engage community experts and their trainees in curating, updating and utilizing content.
  • Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
  • Facilitate building educational content that describes the latest advancements in the field.


Vision

The global hub for clinical cancer genomic aberrations.


Support

The CCGA is a Cancer Genomics Consortium (CGC)-supported resource.


Leadership

Meet our Editorial Leadership, CCGA Workgroup Members and Communications Liaison.